RUNX2 and breast cancer: Out of the 161 genes involved in enriched pathways between BD and FS found in this study, 129 (80%) were found to be differentially expressed in breast cancer (Fig. 3), including significantly higher expression of Runx2 and Skp2 in both the BD and breast cancer groups (Table S2).